A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

Clinical trial NCT06623890 · RECRUITING

Trial details

NCT number: NCT06623890
Sponsor: Biogen
Status: RECRUITING
Study type: OBSERVATIONAL

Friedreich Ataxia

Start date: 2024-12-12
Primary completion: 2029-10-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.